novartis-follows-time-warner-twitter-to-join-malaria-campaign

Novartis follows Time Warner, Twitter to join malaria campaign...

Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power of One campaign to help close the treatment... Read more

the-who-is-concerned-that-in-the-south-east-asia-region-the-malaria-parasite-is-becoming-resistant-to-some-of-the-drugs-that-have-helped-make-progress

WHO launches emergency response to drug resistance

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and controlling malaria in high-burden countries in... Read more

astar-veredus-launch-lab-on-chip

A*Star, Veredus launch Lab-on-Chip

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories have launched VereTrop, the first biochip in the molecular diagnostics market... Read more

while-novartis-incoming-chairman-dr-joerg-reinhardt-will-get-usd4

Novartis to pay $4mn to incoming chairman

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis revealed that it would pay Dr Joerg Reinhardt, the firm's incoming chairman of the board (effective August 1, 2013), a total annual compensation... Read more

good-news-for-ischemia-patients-phylogica-gets-european-patent-for-its-peptide-inhibitors-that-target-the-ap-1-pathway

EU patent for Phylomer ischemia peptides

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: ‘Peptide inhibitors of c-Jun dimerization and uses thereof'. This international... Read more

oncotest-debiopharm-identify-biomarker-candidates

Oncotest, Debiopharm identify biomarker candidates

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first biomarker projects at Oncotest. The pharmacological... Read more

lonza-manufactures-bionomics-anti-cancer-stem-cell-candidate-bnc101

Lonza produces Bionomics’ stem cell cancer drug

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies.... Read more

gavi-alliance-gets-biological-e-pentavalent-vaccines-for-just-usd1

Biological E cuts vaccine cost by 30% for GAVI

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: The GAVI Alliance signed a supply agreement with Biological E, India, according to which it will receive the latter's five-in-one vaccince for just $1.19... Read more

sygnis-pharma-s-flagship-product-qualiphi-gets-us-patent

Sygnis DNA polymerase Qualiphi gets US patent

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Sygnis Pharma has been granted a patent by the US patent and trademark office (US PTO) for its flagship product, Qualiphi, which is a polymerase that... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X